3rd Quarter - Termination

WILLIAMS AND JENSEN, PLLC for MT PHARMA AMERICA, INC.

Firm
Client
Income
$20,000
Expenses
—
Terminated
Aug 31, 2024

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases. General education about federal policies impacting pharmaceutical development, approval, and reimbursement.

LobbyistCovered position, as disclosed
NICOLE MARIE RUZINSKI BERTSCH —
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act and therapies for rare diseases; matters affecting infusion therapies. General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.

LobbyistCovered position, as disclosed
NICOLE MARIE RUZINSKI BERTSCH —
KARINA LYNCH Staff, Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.